Altogether, our study provides insights into the significant role of SLC25A21 in KRAS-mutant CRC and the relevant mechanisms, and these findings may contribute to the development of new therapeutic strategies for KRAS-mutation-driven CRC. The gene discussed is SLC25A21; the disease is colorectal carcinoma.